Zolmitriptan is an oral, selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. It is a second-generation triptan, for acute treatment of migraine attacks with or without aura and cluster headaches.
Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Greece & Argentina) and AscoTop (Germany).

DrugDigest: Zolmitriptan - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.
MEDLINEplus: Zolmitriptan - Features information about dosage, usage, warnings, and side effects.
Meta Description: [ Zolmitriptan (Systemic) ]
Zomig - Features information for US consumers and health care professionals, including detailed migraine information.
Meta Description: [ For migraine headache relief, you can rely on ZOMIG� (zolmitriptan). This AstraZeneca ZOMIG� migraine relief Web site offers information on treatment of migraine headache for patients and physicians. ]
| Nostril Errors with Nasal Sprays (Oct. 2006) | |